For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Stage 1: Octave-Ultherapy Treatment | Subjects received a single Octave-Ultherapy treatment of the brow, face, and neck on Day 1 of Stage 1 with two transducers. | 0 | None | 0 | 10 | 5 | 10 | View |
| Stage 2: Octave-Ultherapy Treatment | Subjects received a single Octave-Ultherapy treatment of the brow, face, and neck on Day 1 of Stage 2 with up to four transducers. | 0 | None | 1 | 40 | 5 | 40 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Follicular lymphoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 25.1 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Application site pain | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25.1 | View |
| Application site pruritus | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25.1 | View |
| Application site urticaria | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25.1 | View |
| Application site discomfort | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25.1 | View |
| Application site dysaesthesia | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 25.1 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 25.1 | View |
| Diverticulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 25.1 | View |